Preparation and in vivo evaluation of a dry powder for inhalation of capreomycin
- PMID: 17657592
- DOI: 10.1007/s11095-007-9381-6
Preparation and in vivo evaluation of a dry powder for inhalation of capreomycin
Abstract
Purpose: To develop an aerosol system for efficient local lung delivery of a tuberculostatic drug.
Methods: The antibiotic, capreomycin sulfate, was spray dried to form a dry powder aerosol. The chemical content and physical properties of resulting particles were assessed under various storage conditions. Plasma concentrations of capreomycin after insufflation into guinea pigs were evaluated at three doses, and compared to IV and IM administration of a capreomycin solution.
Results: Dry powder aerosols containing capreomycin were formulated to enable efficient delivery of large drug masses to the lungs of guinea pigs. Aerosols loaded with 73% CS were shown to possess good aerosolization properties and physical-chemical stability for up to 3 months at room temperature. Upon insufflation into guinea pigs, the amount of CS reaching the bloodstream was significantly lower compared to IV or IM administration, but resulted in a significantly longer drug half-life.
Conclusions: The results indicate that large doses of capreomycin in dry powder form can be efficiently delivered to the lungs of guinea pigs, which may result in high local drug exposure but significantly reduced systemic exposure as suggested by plasma concentrations in the present studies. These systems have considerable potential to provide more effective therapy for MDR-TB.
Similar articles
-
Capreomycin inhalable powders prepared with an innovative spray-drying technique.Int J Pharm. 2014 Jul 20;469(1):132-9. doi: 10.1016/j.ijpharm.2014.04.042. Epub 2014 Apr 18. Int J Pharm. 2014. PMID: 24747443
-
Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model.Antimicrob Agents Chemother. 2007 Aug;51(8):2830-6. doi: 10.1128/AAC.01164-06. Epub 2007 May 21. Antimicrob Agents Chemother. 2007. PMID: 17517845 Free PMC article.
-
A Spray-Dried Combination of Capreomycin and CPZEN-45 for Inhaled Tuberculosis Therapy.J Pharm Sci. 2019 Oct;108(10):3302-3311. doi: 10.1016/j.xphs.2019.05.024. Epub 2019 May 29. J Pharm Sci. 2019. PMID: 31152746 Free PMC article.
-
The role of particle properties in pharmaceutical powder inhalation formulations.J Aerosol Med. 2002 Fall;15(3):325-30. doi: 10.1089/089426802760292672. J Aerosol Med. 2002. PMID: 12396421 Review.
-
Pharmaceutical aerosols for the treatment and prevention of tuberculosis.Front Cell Infect Microbiol. 2012 Sep 7;2:118. doi: 10.3389/fcimb.2012.00118. eCollection 2012. Front Cell Infect Microbiol. 2012. PMID: 22973562 Free PMC article. Review.
Cited by
-
Dry powder nitroimidazopyran antibiotic PA-824 aerosol for inhalation.Antimicrob Agents Chemother. 2009 Apr;53(4):1338-43. doi: 10.1128/AAC.01389-08. Epub 2009 Jan 12. Antimicrob Agents Chemother. 2009. PMID: 19139288 Free PMC article.
-
Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder Inhaler.Pharmaceutics. 2021 Sep 21;13(9):1528. doi: 10.3390/pharmaceutics13091528. Pharmaceutics. 2021. PMID: 34575603 Free PMC article. Review.
-
Aerosol Dynamics in the Respiratory Tract of Food-Producing Animals: An Insight into Transmission Patterns and Deposition Distribution.Animals (Basel). 2025 May 12;15(10):1396. doi: 10.3390/ani15101396. Animals (Basel). 2025. PMID: 40427273 Free PMC article.
-
Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration.Pharm Res. 2009 Jul;26(7):1752-63. doi: 10.1007/s11095-009-9886-2. Epub 2009 May 5. Pharm Res. 2009. PMID: 19415471 Free PMC article.
-
A dry powder combination of pyrazinoic acid and its n-propyl ester for aerosol administration to animals.Int J Pharm. 2016 Dec 5;514(2):384-391. doi: 10.1016/j.ijpharm.2016.04.063. Epub 2016 Apr 26. Int J Pharm. 2016. PMID: 27130363 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources